Results 21 to 30 of about 1,562,206 (187)

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review [PDF]

open access: yesTuberculosis and Respiratory Diseases
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that accelerate disease progression, increase hospitalizations, and elevate mortality.
Hyun Woo Lee
doaj   +1 more source

Investigation of the assortment of medicines for the treatment of chronic obstructive pulmonary disease in the pharmaceutical market of Ukraine

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2020
The aim of the work – to analyze the assortment of medicines for the treatment of chronic obstructive pulmonary disease (COPD) (bronchodilator therapy (BT). in the modern pharmaceutical market of Ukraine. Materials and Methods.
L. I. Budniak , Ye. Yu. Dynia
doaj   +1 more source

New Concepts in Bronchial Asthma

open access: yesSouth African Family Practice, 1992
No abstract available.
Adrian J. Morris
doaj   +1 more source

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil

open access: yesJornal Brasileiro de Pneumologia
Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil.
Martti Anton Antila   +7 more
doaj   +2 more sources

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation

open access: yesLung India, 2016
Context: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) is widely used in the treatment of moderate-to-severe asthma uncontrolled by ICS alone. Aims: To evaluate the efficacy and safety of a new ICS-LABA combination
Sundeep S Salvi   +3 more
doaj   +1 more source

The effect of oral corticosteroids on bronchodilator responses in COPD

open access: yes, 1998
There have been suggestions that corticosteroid treatment might improve bronchodilator responses in chronic obstructive pulmonary disease (COPD). We have studied bronchodilator responses to salbutamol and to oxitropium bromide in 20 patients with stable ...
Rees, P.J., Corden, Z.
core   +1 more source

Data_EurClinRespJ.xlsx

open access: yes, 2023
Factors were studied which determine bronchodilator response to different agents in patients with suspected asthma or ...
Zsofia Lazar (17101969)
core   +1 more source

Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019

open access: yesInternational Journal of COPD, 2023
Manuel Enrique Machado-Duque,1,2 Andrés Gaviria-Mendoza,1,2 Luis Fernando Valladales-Restrepo,1,2 Andrés González-Rangel,3 Maria Eugenia Laucho-Contreras,3,4 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia,
Machado-Duque ME   +5 more
doaj  

Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles

open access: yesPharmaceutical Biology, 2020
Context Curcumin, the active component of Curcuma longa L. (Zingiberaceae), exhibits a wide variety of biological activities including vasodilation and anti-inflammation.
Bahman Emami   +7 more
doaj   +1 more source

The Ideal Bronchodilator

open access: yes, 1979
From the clinician's standpoint, an ideal bronchodilator should have (1) selectivity for bronchial smooth muscle, (2) minimal stimulatory effects on the cardiovascular and central nervous system, (3) prolonged action, (4) rapid onset of action, and (5 ...
Wanner, Adam, Adam Wanner
core   +1 more source

Home - About - Disclaimer - Privacy